Call Us: 1.800.873.5297

By

Mirena MDL Update: Judge Dismisses 31 Cases as Time-Barred

  On January 9, Judge Cathy Seibel, who presides over the Mirena MDL in the Southern District of New York (In re: Mirena® IUD Products Liability Litigation, MDL 2434), granted Bayer’s motion to dismiss 31 cases as time-barred under Louisiana, California, Oklahoma and Ohio law. Judge Seibel ruled that none of these plaintiffs’ claims are […]

By

TVM Lawsuit Update (MDL 2187): Judge Denies C.R. Bard’s Request for New Trial

Judge Joseph Goodwin, who presides over the C.R. Bard MDL pending in the Southern District of West Virginia (In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation, MDL 2187), has denied C.R. Bard’s motion for a new trial on the basis that the manufacturer was not deprived of a fair trial in a […]

By

Xarelto® Litigation Update: Mass Tort Created in Philadelphia State Court

On January 21, Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas issued an Order transferring Xarelto cases currently on file in Philadelphia state court to the court’s mass tort docket for coordination. The cases will be transferred to the court’s Complex Litigation Center for further management. Plaintiffs allege that Xarelto® was introduced […]

By

FDA Approves New Blood Thinning Medication Savaysa (Edoxaban)

The FDA announced that it has approved Savaysa (edoxaban), an anti-clotting drug manufactured by Tokyo-based Daiichi Sankyo and used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problems. Savaysa has also been approved by the FDA to treat […]

By

Daiichi Sankyo Pays $39 Million to Settle False Claims Act Lawsuit

Law 360 reports that Daiichi Sankyo Inc., a Japanese pharmaceutical giant, has agreed to pay $39 million to the Massachusetts government and state Medicaid problems in order to settle a False Claims Act (FCA) lawsuit alleging that the company paid kickbacks to physicians to encourage prescriptions of the company’s cholesterol and blood pressure medications (U.S. […]

By

JPML Will Hear Motion to Centralize Cases Involving Takata Airbags (MDL 2599) During January Session

On January 29, 2015, a hearing before the Judicial Panel on Multidistrict Litigation (JPML) will take place in Miami, Florida regarding the potential Takata Airbag MDL (In re: Takata Airbag Products Liability Litigation, MDL No. 2599). During this hearing, plaintiffs and defendants will present their arguments to the panel as to whether all federally-filed Takata […]

By

TVM MDL Update (MDL 2187): C.R. Bard Transvaginal Mesh Litigation Moves Forward

On December 17, 2014, Judge Joseph Goodwin, the federal judge overseeing the C.R. Bard Multidistrict Litigation (MDL 2187) in West Virginia, issued an order designating sixty (60) transvaginal mesh (TVM) cases involving the manufacturer C.R. Bard as ‘Miniwave 1’ cases. Per a previous order issued by the Court on December 10, 2014, these cases will […]

By

FDA Requires Black Box Warning for Power Morcellators

The Wall Street Journal reports that the Food and Drug Administration (FDA) has called for an immediate ‘Black Box Warning’ for power morcellators, which is “the strongest caution the agency issues.” William Maisel, deputy director for science and chief scientist at the FDA’s Center for Devices and Radiological Health, said, “We believe that in the vast […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.